What is pulsed field ablation?
Pulsed field ablation (PFA) is a nonthermal ablative modality that uses a short-living, strong electrical field created around a catheter to create microscopic pores in cell membranes (electroporation). Clinical trial results, FDA approvals*, capital requirements and reimbursement considerations all culminate in a complex landscape.
We are closely monitoring the progress of PFA and are helping healthcare providers gain insight into how these changes may impact care pathways for cardiac patients, sharing best practices when adopting the new technology and exploring strategic considerations when partnering with medical device suppliers in this dynamic environment.
*The status of FDA approval should be confirmed prior to engaging in a commitment agreement for capital or disposables. CFR21.812.7 prohibits suppliers from promoting or marketing a device until after FDA has approved it for commercial distribution.
- Webinar recording: EP program best practices and the anticipated impact of new PFA technology
- Learn about a-fib programs, PFA adoption considerations and left atrial appendage closures in this interview featuring Dr. Goyal from Piedmont Health
- Explore cardiac ablation modalities
- Optimize your electrophysiology program
- New data point to early intervention for Afib patients
- Podcasts featuring Dr. Munger, Chair of the Heart Rhythm Division at Mayo Clinic
- Webinar recording: Medical Device Tech Watch, Vol. 3 featuring several cardiovascular experts discussing key trends and new industry guidelines
Ready to learn more?
Connect with a Vizient subject matter expert to evaluate strategic considerations such as clinical trial data, capital investments and financial implications of this evolution in cardiac care.